Compare EVH & TCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVH | TCPC |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Finance/Investors Services |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 468.7M | 517.5M |
| IPO Year | 2015 | 2012 |
| Metric | EVH | TCPC |
|---|---|---|
| Price | $4.09 | $5.91 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 14 | 2 |
| Target Price | ★ $12.25 | $6.50 |
| AVG Volume (30 Days) | ★ 4.2M | 576.3K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 20.10% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,054,052,000.00 | $219,119,058.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $28.55 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.50 | $5.39 |
| 52 Week High | $12.98 | $9.72 |
| Indicator | EVH | TCPC |
|---|---|---|
| Relative Strength Index (RSI) | 38.83 | 47.41 |
| Support Level | $3.81 | $5.87 |
| Resistance Level | $4.29 | $6.25 |
| Average True Range (ATR) | 0.20 | 0.12 |
| MACD | 0.15 | -0.01 |
| Stochastic Oscillator | 56.46 | 18.82 |
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.